Dysfunction at the FDA, NIH, Elsewhere | Predictions for 2025
Predictions for this year from Perry Cohen, Pharm.D., CEO of the TPG Family of Companies and Managed Healthcare Executive editorial advisory board member.
The government’s role in impacting healthcare will be huge in 2025. The Trump administration’s primary objective is focused on undoing the work of previous administrations. They will disrupt healthcare delivery and financing by having people in leadership positions driven by politics and ideology who are not knowledgeable about and committed to the importance of evidence-based science and equitable social policy in advancing and regulating healthcare. HHS, the CDC, the FDA and the National Institutes of Health will lose considerable expertise and become dysfunctional.
Cohen
Access to healthcare will decrease due to undermining or eliminating the Affordable Care Act (ACA). Decreased funding for Medicaid will mean tighter requirements for enrollees. The tightening will be more severe in red states.
Quality of healthcare will decrease due to political and ideology-driven policy at both the federal and state levels due to the changes in Congress and at HHS and the impact of the Supreme Court’s Chevron decision. The out-of-pocket cost of healthcare will skyrocket for patients due to reductions in the ACA, Medicaid and cheap versions of health insurance with limited coverage. Medicare will prioritize Medicare Advantage plans over fee-for-service care, and for-profit healthcare companies will be the beneficiary.
FDA Approves First At-Home Cervical Cancer Screening Device
May 15th 2025Self-collected samples to test for cervical cancer are a step in the right direction when it comes to addressing healthcare barriers, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in the Department of Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
The First Financial Toxicity Tumor Board Reports Success in Individual Patient Savings
May 14th 2025Financial toxicity can affect patient outcomes and quality of life. For example, a patient may forgo treatment or medications to save money, or they may incur high medical debt or go into bankruptcy to pay for medical care.
Read More
